Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients

Title: Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients
Authors: Panuccio G.; Correale P.; d'Apolito M.; Mutti L.; Giannicola R.; Pirtoli L.; Giordano A.; Labate D.; Macheda S.; Carabetta N.; Abdelwahed Y. S.; Landmesser U.; Tassone P.; Tagliaferri P.; De Rosa S.; Torella D.
Contributors: Panuccio, G.; Correale, P.; D'Apolito, M.; Mutti, L.; Giannicola, R.; Pirtoli, L.; Giordano, A.; Labate, D.; Macheda, S.; Carabetta, N.; Abdelwahed, Y. S.; Landmesser, U.; Tassone, P.; Tagliaferri, P.; De Rosa, S.; Torella, D.
Publication Year: 2025
Collection: Università degli Studi di Siena: USiena air
Subject Terms: Cancer therapy; CardioOncology; Cardioprotection; Cardiovascular prevention; Heart failure; Immunotherapy
Description: Immunotherapy represents an emergent and heterogeneous group of anticancer treatments harnessing the human immune-surveillance system, including immune-checkpoint inhibitor monoclonal antibodies (mAbs), Chimeric Antigen Receptor T Cells (CAR-T) therapy, cancer vaccines and lymphocyte activation gene-3 (LAG-3) therapy. While remarkably effective against several malignancies, these therapies, often in combination with other cancer treatments, have showed unforeseen toxicity, including cardiovascular complications. The occurrence of immuno-mediated adverse (irAEs) events has been progressively reported in the last 10years. These irAEs present an extended range of severity, from self-limiting to life-threatening conditions. Although recent guidelines in CardioOncology have provided important evidence in managing cancer treatments, they often encompass general approaches. However, a specific focus is required due to the particular etiology, unique risk factors, and associated side effects of immunotherapy. This review aims to deepen the understanding of the prevalence and nature of cardiovascular issues in patients undergoing immunotherapy, offering insights into strategies for risk stratification and management.
Document Type: article in journal/newspaper
File Description: STAMPA
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/39225869; info:eu-repo/semantics/altIdentifier/wos/WOS:001303751500001; volume:120; issue:1; firstpage:153; lastpage:169; numberofpages:17; journal:BASIC RESEARCH IN CARDIOLOGY; https://hdl.handle.net/11365/1279305; https://pmc.ncbi.nlm.nih.gov/articles/PMC11790807/
DOI: 10.1007/s00395-024-01077-7
Availability: https://hdl.handle.net/11365/1279305; https://doi.org/10.1007/s00395-024-01077-7; https://link.springer.com/article/10.1007/s00395-024-01077-7; https://pmc.ncbi.nlm.nih.gov/articles/PMC11790807/
Rights: info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.66D4895E
Database: BASE